ProCE Banner Activity

Targeting Antigens in AML: New Advances in Antibody–Drug Conjugate and Other Antibody-Based Therapies

Slideset Download
Conference Coverage
Download this slideset from a live ASH symposium reviewing the current and future management of acute myeloid leukemia (AML) using antibody-based therapies including antibody-drug conjugates.

Released: December 04, 2018

Expiration: December 03, 2019

No longer available for credit.

Share

Faculty

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Novartis Pharmaceuticals Corporation

Program Director Disclosure

Program Director

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas